Knock-down of P-glycoprotein reverses taxol resistance in ovarian cancer multicellular spheroids
- PMID: 17143487
Knock-down of P-glycoprotein reverses taxol resistance in ovarian cancer multicellular spheroids
Abstract
We previously established that multicellular ovarian cancer spheroids develop intrinsic multidrug resistance with the appearance of quiescent cell areas. p27 protein is a determinant of such resistance. However, the precise molecular basis of such resistance remains unknown. We demonstrated herein that these multicellular ovarian cancer spheroids expressed high levels of p27 and P-gp protein. Compared with monolayer cells, there is a significant increase in the resistance of spheroids cells to anticancer reagent Taxol. Antisense oligodeoxynucleotide not only mediated down-regulation of p27, but also P-gp expression in multicellular spheroids. Selective small interfering RNAs (siRNA) of P-gp with MDR1-targeted short hairpin RNAs (shRNA) expression vector sensitized the cells to Taxol. These results suggest that both p27 and P-gp can modulate Taxol sensitivity respectively, while p27 requires P-gp for its full function. Increased P-gp protein expression through p27 mediation is one of the major mechanisms of Taxol resistance in ovarian cancer multicellular spheroids.
Similar articles
-
[Impact of cyclin-dependent kinase inhibitor p27 on resistance of ovarian cancer multicellular spheroids to taxol].Zhonghua Yi Xue Za Zhi. 2003 Jan 10;83(1):37-41. Zhonghua Yi Xue Za Zhi. 2003. PMID: 12757643 Chinese.
-
MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.Gynecol Oncol. 2010 Oct;119(1):125-30. doi: 10.1016/j.ygyno.2010.06.004. Epub 2010 Jul 10. Gynecol Oncol. 2010. PMID: 20624637
-
Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids.Cancer Res. 1997 Jun 15;57(12):2388-93. Cancer Res. 1997. PMID: 9192815
-
Induction and reversal of cell adhesion-dependent multicellular drug resistance in solid breast tumors.Hum Cell. 1996 Dec;9(4):257-64. Hum Cell. 1996. PMID: 9183656 Review.
-
Recent attempts at RNAi-mediated P-glycoprotein downregulation for reversal of multidrug resistance in cancer.Med Res Rev. 2013 Jan;33(1):33-53. doi: 10.1002/med.20244. Epub 2011 Apr 26. Med Res Rev. 2013. PMID: 21523793 Review.
Cited by
-
Effects of suberoylanilide hydroxamic acid (SAHA) combined with paclitaxel (PTX) on paclitaxel-resistant ovarian cancer cells and insights into the underlying mechanisms.Cancer Cell Int. 2014 Nov 26;14(1):112. doi: 10.1186/s12935-014-0112-x. eCollection 2014. Cancer Cell Int. 2014. PMID: 25546354 Free PMC article.
-
Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression.Clin Exp Metastasis. 2010 Dec;27(8):557-69. doi: 10.1007/s10585-010-9345-9. Epub 2010 Jul 24. Clin Exp Metastasis. 2010. PMID: 20658178
-
Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.J Oncol. 2012;2012:737981. doi: 10.1155/2012/737981. Epub 2012 Feb 6. J Oncol. 2012. PMID: 22481932 Free PMC article.
-
Inhibition of breast cancer invasion by TIS21/BTG2/Pc3-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes.Oncogene. 2016 Jan 7;35(1):83-93. doi: 10.1038/onc.2015.64. Epub 2015 Mar 23. Oncogene. 2016. PMID: 25798836
-
Inhibition of mdr1 by G-quadruplex oligonucleotides and reversal of paclitaxel resistance in human ovarian cancer cells.Tumour Biol. 2015 Aug;36(8):6433-43. doi: 10.1007/s13277-015-3333-2. Epub 2015 Mar 24. Tumour Biol. 2015. PMID: 25801244
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous